Riad Sherif
Vorstandsvorsitzender bei OCULIS HOLDING AG
Vermögen: 10 Mio $ am 30.04.2024
Aktive Positionen von Riad Sherif
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REVENIO GROUP OYJ | Direktor/Vorstandsmitglied | 08.04.2022 | - |
Independent Dir/Board Member | 08.04.2022 | - | |
OCULIS HOLDING AG | Direktor/Vorstandsmitglied | 01.12.2017 | - |
Vorstandsvorsitzender | 01.12.2017 | - | |
Investor Relations Kontakt | 01.12.2017 | - | |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 01.01.2017 | - | |
XPND Medical SA | Vorsitzender | 01.01.2016 | - |
Gründer | 01.01.2016 | - |
Karriereverlauf von Riad Sherif
Ehemalige bekannte Positionen von Riad Sherif
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EURO BIOT | Direktor/Vorstandsmitglied | 28.02.2023 | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Sanofi-Aventis Algérie SpA | Corporate Officer/Principal | - | - |
Alcon Finland OY | Corporate Officer/Principal | - | - |
Statistik
International
Schweiz | 5 |
Finnland | 3 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 4 |
Commercial Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
REVENIO GROUP OYJ | Health Technology |
OCULIS HOLDING AG | Health Technology |
Private Unternehmen | 6 |
---|---|
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Commercial Services |
Alcon Finland OY | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Sanofi-Aventis Algérie SpA | |
European Biotech Acquisition Corp.
European Biotech Acquisition Corp. Financial ConglomeratesFinance European Biotech Acquisition Corp. is a blank check company which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on January 8, 2021 and is headquartered in Lausanne, Switzerland. | Finance |
XPND Medical SA |
- Börse
- Insiders
- Riad Sherif
- Erfahrung